Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials
If you need an accessible version of this item, please submit a remediation request.
Date
2019-02
Language
English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Abstract
Description
Keywords
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Sayar, H., Cripe, L. D., Saliba, A. N., Abu Zaid, M., Konig, H., & Boswell, H. S. (2018). Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials. Leukemia Research, 77, pp 30-33. https://doi.org/10.1016/j.leukres.2018.12.011
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Leukemia Research
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Author's manuscript